Welcome, Guest: Register On Nairaland / LOGIN! / Trending / Recent / NewStats: 3,153,119 members, 7,818,341 topics. Date: Sunday, 05 May 2024 at 01:11 PM |
Nairaland Forum / Yemkaf's Profile / Yemkaf's Posts
(1) (2) (3) (4) (5) (of 5 pages)
Investment / Re: Us Stocks Pick Alert by yemkaf(m): 4:13pm On Nov 21, 2022 |
benedictuyi: Thanks so much I appreciate. |
Investment / Re: Us Stocks Pick Alert by yemkaf(m): 2:12pm On Nov 20, 2022 |
millennium2012: I opened account with etoro recently, but I am afraid to deposit fund into the account because someone told me they do not support Nigerian user. This made me begin to search online and I got to this your message pls I'll like you to give me comprehensive info about how etoro works. I'll be glad if you could share your contact with me for us to have one-on-one convo. Thank you |
Travel / Re: Need Help With Direction by yemkaf(m): 11:01am On Sep 21, 2021 |
How do I get to ICAN office at Oyigbo from Lekki |
Investment / Re: Crowdfunding Investment Platforms And Options (non Agritech Categories) by yemkaf(m): 11:20pm On Nov 14, 2020 |
MummyIMadeIt: The man is just acting movie, anyways all I need is my money |
Investment / Re: Crowdfunding Investment Platforms And Options (non Agritech Categories) by yemkaf(m): 4:03am On Oct 19, 2020 |
spiceeamiee: If you wouldn't mind check my signature and msg me on WhatsApp I'll like to know more about the platform. |
Investment / Re: Crowdfunding Investment Platforms And Options (non Agritech Categories) by yemkaf(m): 6:12am On Oct 18, 2020 |
spiceeamiee: I checked there website what I saw on there website is more of MLM and not a direct investment. You buy products and discount is given to you then you resell, it's actually a good way to making money but I don't have the time for marketing. 1 Like |
Investment / Re: Crowdfunding Investment Platforms And Options (non Agritech Categories) by yemkaf(m): 12:59am On Sep 11, 2020 |
alex074: Just leave it blank |
Investment / Re: Crowdfunding Investment Platforms And Options (non Agritech Categories) by yemkaf(m): 11:28pm On Sep 09, 2020 |
alex074: I did it online |
Investment / Re: Crowdfunding Investment Platforms And Options (non Agritech Categories) by yemkaf(m): 10:05pm On Sep 08, 2020 |
I got a unit of TheMap CRMi investment today and I got both acknowledgment mail and invoice within 2hours. Waiting till pay day 2 Likes 1 Share |
Business / Re: After NYSC What With #500,000 In My Account? by yemkaf(m): 12:46pm On Aug 23, 2020 |
maximus2:Hello good afternoon bro, I really appreciate your advice. I will like to have a talk with you if you wouldn't mind, check my signature for contact. Thanks. |
Investment / Re: Crowdfunding Investment Platforms And Options (non Agritech Categories) by yemkaf(m): 4:39am On Aug 19, 2020 |
Pepchizy: I think TheMap is the next direction I'll be moving, been following them for a while. But there entry value I saw was about ₦450,000 or there about, and that was what kept me away plus there unorganised website I think @pepchizy should put us through. |
Investment / Re: Us Stocks Pick Alert by yemkaf(m): 12:11pm On May 03, 2020 |
To the boss men and ladies in the house I greet. I am a newbie and know virtually nothing about stock trading but I have been going through this thread from page one till now. Still never done my first trade and still learn I am still on trial and error stage. But despite my shallow knowledge in stock trading I think I found something worth sharing here, but I'll like the senior man in the house to go through it and give there verdict on it. Thanks. Amgen (AMGN) came out with quarterly earnings of $4.17 per share, beating the Zacks Consensus Estimate of $3.70 per share. This compares to earnings of $3.56 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 12.70%. A quarter ago, it was expected that this world's largest biotech drugmaker would post earnings of $3.44 per share when it actually produced earnings of $3.64, delivering a surprise of 5.81%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Amgen, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $6.16 billion for the quarter ended March 2020, surpassing the Zacks Consensus Estimate by 2.53%. This compares to year-ago revenues of $5.56 billion. The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Amgen shares have lost about 2.2% since the beginning of the year versus the S&P 500's decline of -9%. What's Next for Amgen? While Amgen has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Amgen was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $3.93 on $6.31 billion in revenues for the coming quarter and $15.36 on $25.21 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 6% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. 2 Likes |
Investment / Re: Us Stocks Pick Alert by yemkaf(m): 1:19pm On Apr 20, 2020 |
OakPearl:Sir how does one know the stock that pay dividend and the one that doesn't |
(1) (2) (3) (4) (5) (of 5 pages)
(Go Up)
Sections: politics (1) business autos (1) jobs (1) career education (1) romance computers phones travel sports fashion health religion celebs tv-movies music-radio literature webmasters programming techmarket Links: (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) Nairaland - Copyright © 2005 - 2024 Oluwaseun Osewa. All rights reserved. See How To Advertise. 38 |